SOLUBLE HYALURONAN RECEPTOR RHAMM INDUCES MITOTIC ARREST BY SUPPRESSING CDC2 AND CYCLIN B1 EXPRESSION

Citation
S. Mohapatra et al., SOLUBLE HYALURONAN RECEPTOR RHAMM INDUCES MITOTIC ARREST BY SUPPRESSING CDC2 AND CYCLIN B1 EXPRESSION, The Journal of experimental medicine, 183(4), 1996, pp. 1663-1668
Citations number
28
Categorie Soggetti
Immunology,"Medicine, Research & Experimental
ISSN journal
00221007
Volume
183
Issue
4
Year of publication
1996
Pages
1663 - 1668
Database
ISI
SICI code
0022-1007(1996)183:4<1663:SHRRIM>2.0.ZU;2-P
Abstract
The hyaluronan (HA) receptor RHAMM is an important regulator of cell g rowth. Overexpression of RHAMM is transforming and is required for H-r as transformation. The molecular mechanism underlying growth control b y RHAMM and other extracellular matrix receptors remains largely unkno wn. We report that soluble RHAMM induces G(2)/M arrest by suppressing the expression of Cdc2/Cyclin B1, a protein kinase complex essential f or mitosis. Downregulation of RHAMM by use of dominant negative mutant s or antisense mRNA also decreases Cdc2 protein levels. Suppression of Cdc2 occurs as a result of an increased rate of cdc2 mRNA degradation . Moreover, tumor cells treated with soluble RHAMM are unable to form lung metastases. Thus, we show that mitosis is directly linked to RHAM M through control of Cdc2 and Cyclin B1 expression. Failure to sustain levels of Cdc2 and Cyclin B1 proteins leads to cell cycle arrest.